Our clients span the industry, from academic institutions to small emerging biotech start-ups to established vertically integrated pharmaceutical, and biotechnology companies. What our clients have in common is the desire to efficiently move their product from concept to market while minimizing regulatory uncertainty, risk and cost. DSI has professionally served over 150 clients from multiple different countries. Ultimately, our clients' primary goal is to deliver innovative, safe and effective therapies to patients.